Archives
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2019-05
- 2019-04
- 2018-07
-
Palbociclib (PD0332991): Precision CDK4/6 Inhibition in C...
2025-10-19
Palbociclib (PD0332991) Isethionate stands out as a selective CDK4/6 inhibitor, empowering translational cancer research with robust cell cycle control and apoptosis induction. From assembloid modeling to resistance mechanism dissection, this guide delivers actionable protocols and troubleshooting tips to maximize experimental impact.
-
Eltanexor (KPT-8602): Redefining Nuclear Export Inhibitio...
2025-10-18
Explore how Eltanexor (KPT-8602), a second-generation XPO1 inhibitor, is revolutionizing cancer therapeutics by targeting the XPO1/CRM1 nuclear export pathway and modulating Wnt/β-catenin signaling. This in-depth analysis uncovers nuanced mechanisms and emerging applications distinct from existing overviews.
-
Deferasirox and the Iron Metabolism Frontier: Strategic I...
2025-10-17
This thought-leadership article charts the paradigm shift catalyzed by Deferasirox—a potent oral iron chelator—at the intersection of iron chelation therapy, cancer research, and ferroptosis resistance. Integrating the latest mechanistic insights, including the METTL16-SENP3-LTF axis in hepatocellular carcinoma, it delivers actionable strategies for translational researchers aiming to exploit iron-dependent vulnerabilities in oncology. Distinct from standard product pages, this piece contextualizes Deferasirox within evolving therapeutic landscapes and provides a visionary blueprint for future innovation.
-
7-Ethyl-10-hydroxycamptothecin: Advanced Workflows for Co...
2025-10-16
Leverage the dual-action power of 7-Ethyl-10-hydroxycamptothecin as both a DNA topoisomerase I inhibitor and apoptosis inducer in metastatic colon cancer models. This article delivers robust, data-driven protocols, troubleshooting strategies, and highlights emerging mechanisms—including FUBP1 pathway modulation—that position this compound at the cutting edge of advanced colon cancer research.
-
DRB (HIV Transcription Inhibitor): Unveiling New Frontier...
2025-10-15
Explore the multifaceted research potential of DRB, a potent transcriptional elongation and CDK inhibitor. This article provides a deep-dive into DRB’s unique mechanisms, its role in RNA polymerase II regulation, and its expanding applications in HIV, cancer, and cell fate research—offering fresh insights beyond existing literature.
-
The study by Lo http www apexbt
2025-03-03

The study by Lowry et al. (2001) pointed toward functionally uncharacterized DA- and 5-HT-accumulating neurons within the DMH as a potential target for rapid nongenomic effects of CORT. Similar DA- and 5-HT-accumulating systems are distributed throughout the central and peripheral nervous systems, s
-
br Conflict of interest br Acknowledgements The authors
2025-03-03

Conflict of interest Acknowledgements The authors would like to thank Mrs. Amparo Pacheco from CMPL, PUC, for her technical and secretarial assistance. This work was supported by the Fondo Nacional de Desarrollo Científico y Tecnológico (FONDECYT 1150344, 1050377, 11150083), and the Direccioń
-
In summary we suggest that both cofilin
2025-03-03

In summary, we suggest that both cofilin and gelsolin are essential factors that regulate sperm capacitation and the acrosomal exocytosis by modulating actin. The relationships between activation/inactivation of cofilin and gelsolin suggest that inhibition of cofilin is important for allowing F-acti
-
For some fishstocks landed by FMA ACE fishers the
2025-03-03

For some fishstocks landed by FMA3 ACE fishers, the designated Quota Management Area (QMA) extends beyond the geographic demarcations of FMA3.Fig. 1 shows the ten FMAs, highlighting the study area FMA3. Gurnard 3 QMA is included as an example of a QMA that (R)-PFI 2 hydrochloride extends across mor
-
On the contrary evidence also suggests that autophagy plays
2025-03-03

On the contrary, evidence also suggests that autophagy plays a striking protective role in cancer cells. Highly burgeoning cancer PRT-060318 sale require cellular building blocks for their metabolism and energy production. At this stage of cancer development, autophagy acts as a friend providing al
-
The analysis of the profile of protein phosphorylation in
2025-03-01

The analysis of the profile of protein phosphorylation in MMS-treated TH588 confirmed that both the ATM and ATR pathways were activated in S-phase blocked cells. Interestingly, phosphorylation of Chk1 was observed 24h after MMS-treatment both in AT- and ATM-inhibited cells, whilst in the absence of
-
We next sought to determine the kinase
2025-03-01

We next sought to determine the kinase responsible for IR-induced phosphorylation of 53BP1. Because the sites under investigation all lie in a consensus sequence for ATM, ATR and DNA-PK, that are all activated by IR, the involvement of each of these kinases was investigated. Preincubation of p2x7 an
-
br Current limitations and future directions
2025-03-01

Current limitations and future directions There are several limitations associated with PET imaging of aromatase using carbon-11 labeled aromatase inhibitors. Due to the very short half-life of carbon 11 (20min), PET studies with currently available, validated tracers can only be performed in med
-
The enzyme Arginase ARG plays a
2025-03-01

The enzyme Arginase 1 (ARG1) plays a role in the hepatic urea cycle by hydrolyzing L-arginine to L-ornithine and urea [13]. In the context of macrophages and MDSCs, ARG1 expression redirects L-arginine metabolism to abolish cytotoxic nitric oxide production [14], suppress T-cell function [15], [16],
-
Additionally we used the predicted Cyp a b amino acid
2025-03-01

Additionally, we used the predicted Cyp19a1b amino gsk3 inhibitor sequence from a number of bony fish species to infer their genetic relatedness and found that R. quelen occupies an ancient position within the Siluriformes group. A phylogenetic tree was constructed and it included both full-length
15721 records 7/1049 page Previous Next First page 上5页 678910 下5页 Last page